Topics covered include: the global market in a historical context; and the outlook of "macro misery", having regard to unemployment, inflation, and the likelihood of recession and tighter monetary policy.
Copyright 2022 – Finance News Network
28 Sep 2020 - Cyclopharm Limited (ASX:CYC) Managing Director and CEO James McBrayer provides an update on the company's US Phase 3 trial for Technegas, and USFDA approval process timeline, with commercial sales expected in the US for 2021.
02 Nov 2022 - Novonix Limited (ASX:NVX) CEO Dr Chris Burns discusses news following the company's AGM, including the appointment of new directors and the expansion of the company's development capabilities.
07 Mar 2023 - Eureka Group Holdings Limited (ASX:EGH) CEO Cameron Taylor provides an overview of the company, discussing positioning in the industry, strategy, the new development in Brassall, Queensland, government assistance and growth opportunities.
01 May 2020 - Acorn Capital, Head of Portfolio Implementation and Portfolio manager (Healthcare and Biotechnology sectors) Paul Palumbo looks the microcap sector and the recent market sell off and discusses the outlook for next 6 months and longer term.
26 Sep 2024 - QX Resources Limited (ASX:QXR) Managing Director Steve Promnitz discusses the company's renegotiation of the option agreement for the Liberty Lithium Brine Project, which now allows for opportunities in two additional lithium projects in Nevada and Utah. He highlights the strategic importance of being positioned in the US lithium market amid growing demand for battery minerals.
02 Oct 2024 - Lithium Universe Limited (ASX:LU7) CEO Alex Hanly discusses the company's prefeasibility study, operational costs and development timeline.
09 March 2023 - Knosys Limited (ASX:KNO) Managing Director John Thompson discusses drivers of revenue growth, the roadmap for the company's three SaaS solutions, onshoring GreenOrbit operations and outlook for the second half.